Ask Warren

Humedix

200670 · KOSDAQ · ₩200670 · 휴메딕스

₩23,000▼ ₩700 (2.95%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩50B₩41B₩46B₩41B₩43B₩40B₩37B₩37B
Cost of sales₩27B₩22B₩25B₩23B₩23B₩20B₩20B₩21B
Gross profit₩23B₩18B₩21B₩18B₩20B₩20B₩18B₩16B
Operating income₩12B₩8.9B₩11B₩9B₩11B₩11B₩10B₩9.2B
Net income₩2.4B₩13B₩7.8B₩23B₩7.9B₩13B₩11B₩6.8B
Net income to shareholders₩2.4B₩13B₩7.8B₩23B₩7.9B₩13B₩11B₩6.8B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩335B₩338B₩324B₩289B₩269B₩266B₩250B₩236B
Current assets₩176B₩183B₩179B₩183B₩183B₩181B₩160B₩148B
Cash and equivalents₩47B₩50B₩40B₩65B₩75B₩117B₩110B₩96B
Total liabilities₩26B₩28B₩24B₩23B₩21B₩27B₩21B₩19B
Current liabilities₩24B₩23B₩21B₩20B₩19B₩26B₩19B₩18B
Borrowings——————₩0—
Total equity₩308B₩311B₩300B₩265B₩248B₩239B₩229B₩217B
Shareholders' equity₩308B₩311B₩300B₩265B₩248B₩239B₩229B₩217B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩5.7B₩8B₩15B₩9.7B₩9.6B₩10B₩16B₩14B
Capital spending₩5.6B₩743M₩3.9B₩2.7B₩403M₩862M₩1.4B₩968M
Free cash flow₩72M₩7.3B₩12B₩7B₩9.2B₩9.5B₩15B₩14B
Dividends paid₩2.2B₩2.2B₩5.9B₩1.6B₩3.4B₩0₩0₩3.1B

Consolidated where available. Amounts in won.

Also known as: Humedix / 휴메딕스 / 200670 / KRX:200670

Source: KRX statistical information